BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 7, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 22, 2002
View Archived Issues
Other News To Note
Read More
Teva’s Copaxone Failure In MS Attributed To Low Relapse Rate
Read More
Orchid Raises $23M Through Public Offering Of 8M Shares
Read More
Appointments And Advancements
Read More
Use Partners To Pack Pipeline But Not Too Early, Panel Says
NEW YORK - Partners matter. But products matter more, and the one can be used to reach the other, said Donald Drakeman, president and CEO of Medarex Inc., the transgenic mouse company with “about four dozen” collaborators. (BioWorld Today)
Read More
Cure, Not Just Therapy, Target For Cardio Drugs And Devices
Read More
Isis, Merck Form Collaboration Centered On Target Validation
Read More
Cypress Enters Deal To Raise $17M, If Shareholders Approve
Read More
